• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI乳腺摄影检测出的遗传易感性个体在进行降低风险的乳房切除术后影响残留乳腺腺体组织的因素。

Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography.

作者信息

Dietzel Frederic, Kolberg Leoni, Vesper Anne Sophie, Hoffmann Jürgen, Nestle-Krämling Carolin, Zwiefel Karin, Friebe Verena, Sawicki Lino M, Bruckmann Nils Martin, Jannusch Kai, Morawitz Janna, Antoch Gerald, Fehm Tanja Natascha, Kirchner Julian, Mohrmann Svjetlana

机构信息

Department of Diagnostic and Interventional Radiology, Medical Faculty, University Dusseldorf, 40225 Dusseldorf, Germany.

Department of Obstetrics and Gynecology, Medical Faculty, University Dusseldorf, 40225 Dusseldorf, Germany.

出版信息

Cancers (Basel). 2023 Jan 29;15(3):829. doi: 10.3390/cancers15030829.

DOI:10.3390/cancers15030829
PMID:36765786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9913581/
Abstract

PURPOSE

This study seeks to evaluate MR imaging morphological factors and other covariates that influence the presence of residual glandular tissue after risk-reducing mastectomy in patients with a familial predisposition.

METHODS

We analyzed women of a high-risk collective with pathogenic mutation (BRCA1 (n = 49), BRCA2 (n = 24), or further mutation (n = 9)). A total of 117 breasts were analyzed, 63 left and 54 right, from a cohort of 81 patients, who were on average 40 years old. The mean follow-up was 63 months (range 12-180 months, SD = 39.67). Retrospective analysis of MR imaging data from 2006-2022 of patients of a high-risk collective (all carriers of a pathogenic mutation) with contralateral (RRCM) or bilateral risk-reducing mastectomy (RRBM) was performed. In the image data the remaining skin flap thickness by distance measurements at eight equally distributed, clockwise points and the retromamillary area, as well as by volumetry of each breast, was elected. Residual glandular tissue was also volumetrized. In addition, patient-related covariates were recorded and their influence on postoperative residual glandular tissue and skin flap thickness was analyzed by uni- and multivariate regressions.

RESULTS

A significant association with postoperative residual glandular tissue was shown in multivariate analysis for the independent variables breast density, skin flap mean, and surgical method (all -values < 0.01). A negatively significant association could be seen for the variables preoperative breast volume (-values < 0.01) and surgeon experience (most -values < 0.05-<0.1).

CONCLUSION

Postoperative residual glandular tissue is an important tool for quantifying the risk of developing breast cancer after risk-reducing mastectomy. Different effects on residual glandular tissue were shown for the independent variables breast density, skin flap, surgical method, preoperative breast volume, and surgeon experience, so these should be considered in future surgical procedures preoperatively as well as postoperatively. Breast MRI has proven to be a suitable method to analyze the skin flap as well as the RGT.

摘要

目的

本研究旨在评估影响有家族性易患倾向患者行降低风险乳房切除术后残留腺组织存在情况的磁共振成像(MR)形态学因素及其他协变量。

方法

我们分析了一个高危群体中携带致病突变的女性(BRCA1基因携带者49例、BRCA2基因携带者24例或其他突变携带者9例)。对81例平均年龄40岁患者的117个乳房进行了分析,其中左侧63个,右侧54个。平均随访时间为63个月(范围12 - 180个月,标准差 = 39.67)。对2006 - 2022年高危群体(所有致病突变携带者)中行对侧降低风险乳房切除术(RRCM)或双侧降低风险乳房切除术(RRBM)患者的MR成像数据进行回顾性分析。在图像数据中,通过在八个等距、顺时针分布的点测量皮瓣厚度以及乳晕后区域,并对每个乳房进行容积测量来选取相关数据。残留腺组织也进行了容积测量。此外,记录患者相关协变量,并通过单因素和多因素回归分析它们对术后残留腺组织和皮瓣厚度的影响。

结果

多因素分析显示,独立变量乳腺密度、皮瓣均值和手术方式与术后残留腺组织存在显著相关性(所有P值 < 0.01)。术前乳房体积(P值 < 0.01)和外科医生经验(大多数P值 < 0.05 - <0.1)与术后残留腺组织呈负显著相关。

结论

术后残留腺组织是量化降低风险乳房切除术后患乳腺癌风险的重要工具。独立变量乳腺密度、皮瓣、手术方式、术前乳房体积和外科医生经验对残留腺组织有不同影响,因此在未来手术操作的术前和术后均应予以考虑。乳腺MRI已被证明是分析皮瓣以及残留腺组织的合适方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/2842a336d470/cancers-15-00829-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/23bb88da7166/cancers-15-00829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/06666bccf86a/cancers-15-00829-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/6242bd1a5dff/cancers-15-00829-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/2d9a99e8bede/cancers-15-00829-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/7499de1ef24d/cancers-15-00829-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/2842a336d470/cancers-15-00829-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/23bb88da7166/cancers-15-00829-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/06666bccf86a/cancers-15-00829-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/6242bd1a5dff/cancers-15-00829-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/2d9a99e8bede/cancers-15-00829-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/7499de1ef24d/cancers-15-00829-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e3/9913581/2842a336d470/cancers-15-00829-g006.jpg

相似文献

1
Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography.MRI乳腺摄影检测出的遗传易感性个体在进行降低风险的乳房切除术后影响残留乳腺腺体组织的因素。
Cancers (Basel). 2023 Jan 29;15(3):829. doi: 10.3390/cancers15030829.
2
Impact of surgical variables on residual glandular tissue in risk-reducing mastectomies: Results of a retrospective monocentric study from a center of the German consortium for hereditary breast and ovarian cancer.手术变量对降低风险乳房切除术残留腺体组织的影响:德国遗传性乳腺癌和卵巢癌联合会中心的回顾性单中心研究结果。
Eur J Surg Oncol. 2023 Nov;49(11):107031. doi: 10.1016/j.ejso.2023.107031. Epub 2023 Aug 24.
3
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
4
Prophylactic mastectomy - Correlation between skin flap thickness and residual glandular tissue evaluated postoperatively by imaging.预防性乳房切除术 - 通过影像学评估术后皮瓣厚度与残留腺组织的相关性。
J Plast Reconstr Aesthet Surg. 2022 Jun;75(6):1813-1819. doi: 10.1016/j.bjps.2022.01.031. Epub 2022 Jan 23.
5
Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.BRCA1/2 种系突变携带者单侧和双侧预防性乳房切除术的残留腺体组织 (RGT)。
Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
6
Inter- and intra-observer agreement on evaluating the presence of residual glandular tissue with magnetic resonance tomography following prophylactic mastectomy.保乳术后磁共振成像评估残留腺体组织的观察者间和观察者内一致性。
Acta Radiol. 2023 Jan;64(1):67-73. doi: 10.1177/02841851211058929. Epub 2021 Dec 1.
7
Analysis of Skin Flap Thickness and Residual Breast Tissue After Mastectomy.乳房切除术后面部皮瓣厚度和残余乳腺组织的分析。
Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):82-91. doi: 10.1016/j.ijrobp.2018.05.023. Epub 2018 May 17.
8
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.以色列无症状 BRCA1 和 BRCA2 突变携带者中降低风险的乳房切除术接受率的时间趋势。
Breast Cancer Res Treat. 2021 Jan;185(2):391-399. doi: 10.1007/s10549-020-05949-z. Epub 2020 Sep 30.
9
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observation.降低风险的对侧乳房切除术后妊娠引起的残余乳腺组织增生——仅仅是有趣的现象还是具有临床重要性的观察结果。
Cancer Treat Res Commun. 2022;30:100504. doi: 10.1016/j.ctarc.2021.100504. Epub 2022 Jan 1.
10
Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction.吲哚菁绿血管造影术在即刻乳房重建中预防乳房切除术后皮瓣坏死的应用
Cochrane Database Syst Rev. 2020 Apr 22;4(4):CD013280. doi: 10.1002/14651858.CD013280.pub2.

引用本文的文献

1
Residual Breast Tissue After Four Types of Mastectomy: A Prospective, Comparative Study.四种乳房切除术后的残余乳腺组织:一项前瞻性比较研究。
Ann Surg Oncol. 2025 Aug;32(8):5467-5476. doi: 10.1245/s10434-025-17350-5. Epub 2025 Apr 24.
2
Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study.乳房切除术后残留纤维腺体组织的风险因素——综述和回顾性队列研究。
BMC Cancer. 2024 Jul 18;24(1):856. doi: 10.1186/s12885-024-12491-4.
3
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction.

本文引用的文献

1
Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures.全球乳腺癌发病率上升:风险因素和预防措施。
Biomed Res Int. 2022 Apr 18;2022:9605439. doi: 10.1155/2022/9605439. eCollection 2022.
2
Nipple Sparing Mastectomy as a Risk-Reducing Procedure for BRCA-Mutated Patients.保留乳头的乳房切除术作为 BRCA 突变患者的降低风险手术。
Genes (Basel). 2021 Feb 10;12(2):253. doi: 10.3390/genes12020253.
3
Residual Glandular Breast Tissue After Mastectomy: A Systematic Review.乳房切除术后残余乳腺组织:系统评价。
BRCA 研究新进展:乳房切除术和重建术后残留的乳腺组织。
Breast Cancer Res Treat. 2024 Nov;208(2):359-367. doi: 10.1007/s10549-024-07425-4. Epub 2024 Jul 9.
Ann Surg Oncol. 2020 Jul;27(7):2288-2296. doi: 10.1245/s10434-020-08516-4. Epub 2020 May 10.
4
Breast cancer prevention in high-risk women.高危女性的乳腺癌预防。
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:18-31. doi: 10.1016/j.bpobgyn.2019.11.006. Epub 2019 Nov 21.
5
Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.乳腺癌化学预防:当前实践的更新和初级保健医生的机会。
Prev Med. 2019 Dec;129:105834. doi: 10.1016/j.ypmed.2019.105834. Epub 2019 Sep 5.
6
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
7
Breast MRI: State of the Art.乳腺 MRI:现状。
Radiology. 2019 Sep;292(3):520-536. doi: 10.1148/radiol.2019182947. Epub 2019 Jul 30.
8
Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.BRCA1/2 种系突变携带者单侧和双侧预防性乳房切除术的残留腺体组织 (RGT)。
Surg Oncol. 2019 Jun;29:126-133. doi: 10.1016/j.suronc.2019.04.009. Epub 2019 May 3.
9
Prospective Evaluation of Residual Breast Tissue After Skin- or Nipple-Sparing Mastectomy: Results of the SKINI-Trial.保乳术后乳房皮肤或乳头残留组织的前瞻性评估:SKINI 试验结果。
Ann Surg Oncol. 2019 May;26(5):1254-1262. doi: 10.1245/s10434-019-07259-1. Epub 2019 Mar 4.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.